Aspen Pharmacare Holdings Limited (FRA:LDZA)

Market Cap	2.88B -29.2%
Revenue (ttm)	2.19B +2.8%
Net Income	-102.83M
EPS	-0.23
Shares Out	n/a
PE Ratio	n/a
Forward PE	13.09
Dividend	0.10 (1.60%)
Ex-Dividend Date	Oct 1, 2025

Volume	n/a
Average Volume	38
Open	6.50
Previous Close	6.70
Day's Range	6.50 - 6.50
52-Week Range	4.50 - 8.50
Beta	n/a
RSI	45.49
Earnings Date	Mar 3, 2026

About Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counte...

• Industry: Pharmaceutical Preparations
• Founded: 1850
• Employees: 9,343
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LDZA

Financial Performance

Financial numbers in ZAR